Gyre Therapeutics Inc.Eigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 5.94 USD | 9,42 USD | 5,44 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 18,667 USD | 1 | 0 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 111.488.849 | 5,81 | 17,38 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Gyre Therapeutics Inc.
Mitarbeiter 625
Handelsplatz NASDAQ
Ticker Symbol GYRE
IPO Datum 2006-04-12
Adresse 12730 High Bluff Drive, San Diego, CA, United States, 92130
Webseite https://www.gyretx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Thomas W. Eastling M.D. | Chief Financial Officer |
| 2 | Mr. Weiguo Ye | Chief Operating Officer |
| 3 | Ms. Ruoyu Chen | Chief Information Officer |
| 4 | Dr. Ying Luo Ph.D. | CEO, President & Director |
| 5 | Dr. Yue Xiong Ph.D. | Chief Scientific Officer |
| 6 | Mr. Joshua Bergmann J.D. | General Counsel & Corporate Secretary |
| 7 | Seth Goldblum M.B.A. | Senior Vice President of Corporate Development |
| 8 | Mr. Jialiang Wang Ph.D. | Executive VP & GM |
| 9 | Jing Liu Ph.D. | Senior Vice President of Platform Chemistry |
| 10 | Mark Marino | Senior Vice President of Clinical Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 3 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 4 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 6 | SBI Securities Co Ltd | 0,00% | 0,00 Mio. USD |
| 7 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Fiduciary Trust Co | 0,00% | 0,00 Mio. USD |
| 9 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 10 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 11 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Bank of New York Mellon Corp | 0,00% | 0,00 Mio. USD |
| 13 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 14 | AllianceBernstein L.P. | 0,00% | 0,00 Mio. USD |
| 15 | STRS OHIO | 0,00% | 0,00 Mio. USD |
| 16 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 17 | FMR Inc | 0,00% | 0,00 Mio. USD |
| 18 | Brevan Howard Capital Management LP | 0,00% | 0,00 Mio. USD |
| 19 | Rhumbline Advisers | 0,00% | 0,00 Mio. USD |
| 20 | Deutsche Bank AG | 0,00% | 0,00 Mio. USD |